We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Scotts Miracle-Gro, Home Depot, Lowe's and RH
Read MoreHide Full Article
For Immediate Release
Chicago, IL – August 2, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: The Scotts Miracle-Gro Company (SMG - Free Report) , The Home Depot, Inc. (HD - Free Report) , Lowe’s Companies, Inc. (LOW - Free Report) and RH (RH - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Buy This Stock Down 30% Before Earnings for Marijuana Growth?
Scotts Miracle-Gro stock soared around 200% during a two-plus year stretch on the back of its exposure to the growing legal marijuana business in North America. The lawn care products firm has since tumbled about 30% from its early April records.
Let’s quickly dive into SMG ahead of its upcoming Q3 earnings report on August 4 to see if it might be worth buying.
Home Projects & Marijuana Exposure
Scotts Miracle-Gro is a consumer lawn and garden products powerhouse that operates under both The Company’s Scotts and Miracle-Gro brands, as well as Ortho. Wall Street has also grew enamored with its Hawthorne Gardening segment, which is a leader in the hydroponic industry. This helps Scotts Miracle-Gro gain huge exposure to the growing marijuana market.
The company’s hydroponic space helped SMG achieve strong top-line expansion over the past two years, with FY19 revenue up 19% and fiscal 2020 sales 31% higher.
Its Hawthorne segment stands to benefit for years if not decades to come as part of the broader push for marijuana legalization in the U.S. and beyond. The hydroponic industry also has legs within the broader indoor farming market that’s poised to catch on in cities and other areas where traditional outdoor agriculture is difficult or impossible.
Scotts Miracle-Gro also benefitted from increased home improvement spending, alongside the likes of Home Depot, Lowe’s, RH, and many others. The housing market is still hot and people are spending more time at home, while craving more space, which often means bigger yards.
What Else
Last quarter, Hawthorne sales surged another 66%, with its total Q2 FY21 revenue up 32%. “Consumers told us entering the season that they intended to stay engaged with lawn and garden and, so far, that is exactly what they are doing,” CEO Jim Hagedorn said in prepared remarks last quarter.
“We also continue to exceed expectations at Hawthorne as we reported our fifth consecutive quarter of sales growth in excess of 60 percent and another month of strong results in April. Given the current momentum of this business, we feel comfortable once again increasing our sales guidance for Hawthorne to a range of 30 to 40 percent growth on a fiscal year basis.”
Management did announce plans to raise prices to help offset what it called “continued commodity pressure.” On top of higher prices, the company is now coming up against some difficult to compare periods after two years of big growth. With this in mind, Zacks estimates call for its Q3 revenue to come in marginally lower vs. the prior-year quarter, with adjusted earnings set to dip 9% to $3.45 a share.
Scotts Miracle-Gro’s fiscal 2021 earnings are still projected to climb 28% on 18% higher revenue to reach $4.9 billion. At the moment, our estimates call for its FY22 revenue and earnings to slip around 3% below these elevated figures. And SMG’s earnings revisions have trended slightly in the wrong direction.
Bottom Line
As we mentioned at the top, the stock has tumbled since it hit over $250 in early April. SMG closed regular hours Thursday down 30% from its records at $178.84 a share. The selling has pushed the stock well below both its 50-day and 200-day moving averages. The downturn has sent SMG shares near oversold RSI (30) levels at 36. The selling appears to be a major recalibration on an overheated stock.
But the company has continually raised its dividend over the years and its yield sits at 1.4%, which tops the 10-year U.S. Treasury. Plus, Wall Street still loves the stock, with six of the seven brokerage recommendations Zacks has at “Strong Buys.”
Scotts Miracle-Gro could also continue to benefit from the housing market and home improvement spending that’s finally being driven by millennials. And, of course, its hydroponic segment stands to keep growing as more states legalize recreational marijuana. That said, some investors might want to wait for signs of a comeback before jumping in on SMG.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Scotts Miracle-Gro, Home Depot, Lowe's and RH
For Immediate Release
Chicago, IL – August 2, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: The Scotts Miracle-Gro Company (SMG - Free Report) , The Home Depot, Inc. (HD - Free Report) , Lowe’s Companies, Inc. (LOW - Free Report) and RH (RH - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Buy This Stock Down 30% Before Earnings for Marijuana Growth?
Scotts Miracle-Gro stock soared around 200% during a two-plus year stretch on the back of its exposure to the growing legal marijuana business in North America. The lawn care products firm has since tumbled about 30% from its early April records.
Let’s quickly dive into SMG ahead of its upcoming Q3 earnings report on August 4 to see if it might be worth buying.
Home Projects & Marijuana Exposure
Scotts Miracle-Gro is a consumer lawn and garden products powerhouse that operates under both The Company’s Scotts and Miracle-Gro brands, as well as Ortho. Wall Street has also grew enamored with its Hawthorne Gardening segment, which is a leader in the hydroponic industry. This helps Scotts Miracle-Gro gain huge exposure to the growing marijuana market.
The company’s hydroponic space helped SMG achieve strong top-line expansion over the past two years, with FY19 revenue up 19% and fiscal 2020 sales 31% higher.
Its Hawthorne segment stands to benefit for years if not decades to come as part of the broader push for marijuana legalization in the U.S. and beyond. The hydroponic industry also has legs within the broader indoor farming market that’s poised to catch on in cities and other areas where traditional outdoor agriculture is difficult or impossible.
Scotts Miracle-Gro also benefitted from increased home improvement spending, alongside the likes of Home Depot, Lowe’s, RH, and many others. The housing market is still hot and people are spending more time at home, while craving more space, which often means bigger yards.
What Else
Last quarter, Hawthorne sales surged another 66%, with its total Q2 FY21 revenue up 32%. “Consumers told us entering the season that they intended to stay engaged with lawn and garden and, so far, that is exactly what they are doing,” CEO Jim Hagedorn said in prepared remarks last quarter.
“We also continue to exceed expectations at Hawthorne as we reported our fifth consecutive quarter of sales growth in excess of 60 percent and another month of strong results in April. Given the current momentum of this business, we feel comfortable once again increasing our sales guidance for Hawthorne to a range of 30 to 40 percent growth on a fiscal year basis.”
Management did announce plans to raise prices to help offset what it called “continued commodity pressure.” On top of higher prices, the company is now coming up against some difficult to compare periods after two years of big growth. With this in mind, Zacks estimates call for its Q3 revenue to come in marginally lower vs. the prior-year quarter, with adjusted earnings set to dip 9% to $3.45 a share.
Scotts Miracle-Gro’s fiscal 2021 earnings are still projected to climb 28% on 18% higher revenue to reach $4.9 billion. At the moment, our estimates call for its FY22 revenue and earnings to slip around 3% below these elevated figures. And SMG’s earnings revisions have trended slightly in the wrong direction.
Bottom Line
As we mentioned at the top, the stock has tumbled since it hit over $250 in early April. SMG closed regular hours Thursday down 30% from its records at $178.84 a share. The selling has pushed the stock well below both its 50-day and 200-day moving averages. The downturn has sent SMG shares near oversold RSI (30) levels at 36. The selling appears to be a major recalibration on an overheated stock.
But the company has continually raised its dividend over the years and its yield sits at 1.4%, which tops the 10-year U.S. Treasury. Plus, Wall Street still loves the stock, with six of the seven brokerage recommendations Zacks has at “Strong Buys.”
Scotts Miracle-Gro could also continue to benefit from the housing market and home improvement spending that’s finally being driven by millennials. And, of course, its hydroponic segment stands to keep growing as more states legalize recreational marijuana. That said, some investors might want to wait for signs of a comeback before jumping in on SMG.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.